microdosing glp 1 for autoimmune GLP-1 conditions: what the research actually shows Microdosing GLP-1 For Autoimmune Health

reported in a cohort study ( n = 16,827) that there was a higher risk of NAION in individuals prescribed semaglutide (HR 4.28) (89)

Two drugs that often come up in these conversations are metformin and Jardiance

A: Cravings can come from blood sugar instability, gut imbalance, or even emotional patterns

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono) Diabetes Care

Safety Considerations The following is a high-level overview, not a complete list of risks or contraindications

Mind meets metabolism Scientists hypothesis that GLP-1 drugs have a role to play in mental health is in part fueled by decades of research that shows that metabolic health and mental health are closely intertwined